Hemodynamic effects of intermittent transdermal nitroglycerin in chronic congestive heart failure
Data up to Jan 2025
Total Citations Per Year
Abstract
References (16)
Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.
1983 • 295 citations
Hemodynamic Effects of Orally Administered Isosorbide Dinitrate in Patients with Congestive Heart Failure
1974 • 247 citations
Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine.
1983 • 192 citations
Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure
1980 • 178 citations
Tolerance to isosorbide dinitrate: rate of development and reversal.
1983 • 147 citations
Human pharmacological studies of a new transdermal system containing nitroglycerin
1982 • 140 citations
Hemodynamic effects of nitroglycerin ointment in congestive heart failure
1976 • 137 citations
Hemodynamic and Hormonal Response to Transdermal Nitroglycerin in Normal Subjects and in Patients With Congestive Heart Failure
1983 • 134 citations
Measurement of cardiac output during exercise by the thermodilution and direct fick techniques in patients with chronic congestive heart failure
1985 • 72 citations
Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure
1986 • 61 citations
Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure
1985 • 57 citations
Nitroglycerin in a Transdermal Therapeutic System in Chronic Heart Failure
1984 • 56 citations
Sustained beneficial hemodynamic responses to large doses of transdermal nitroglycerin in congestive heart failure and comparison with intravenous nitroglycerin
1984 • 56 citations
Pharmaceutical considerations of transdermal nitroglycerin delivery: The various approaches
1984 • 47 citations
Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure.
1985 • 47 citations
Hemodynamic attenuation and the nitrate-free interval: Alternative dosing strategies for transdermal nitroglycerin
1985 • 22 citations